Arthur M. Krieg, Chief Scientific Officer at Checkmate Pharmaceuticals, Inc. (CMPI), bought 500 shares at $13.09 ($7K) on 2021-01-19, disclosed to the SEC on 2021-01-21.
Open-market purchase of $7k CMPI by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CMPI | BUY | 2021-05-19 | $349K | — | Filing → |
| CMPI | BUY | 2021-03-31 | $741K | — | Filing → |
| CMPI | BUY | 2021-03-29 | $290K | — | Filing → |